Archive · 27 May 2025
JN.1 Variant: New Symptoms Emerge Amidst Rising COVID Cases
A new version of COVID-19 called JN.1 is spreading, similar to the Omicron family.
It's thought to spread easier than before.
Typical signs include a mild, ongoing fever and tummy troubles like feeling sick.
People are finding it in different parts of the world, including India.
Current medicines and vaccines still work well.
Doctors suggest getting tested if you think you have symptoms, isolating to prevent spreading, and staying up-to-date with vaccines.
JN.1 is a subvariant of Omicron, first identified in Luxembourg.
It's more transmissible due to spike protein mutations.
Common symptoms include low-grade fever (37.6°C-38.1°C) and gastrointestinal issues like nausea.
The rise in cases is noted in various states of India.
Vaccines and treatments are effective against the new variants.
- Who
- Individuals infected with the JN.1 variant.
- What
- The JN.1 variant of the SARS-CoV-2 virus.
- When
- First identified in Luxembourg in 2023.
- Where
- Various countries including India, with cases rising in several states.
- Why
- To inform the public about the new JN.1 variant and its symptoms.
- Virus Type
- SARS-CoV-2
- Variant Name
- JN.1
- Lineage
- Omicron BA.2.86
- First Identified
- 2023
- Common Symptoms
- Low-grade fever (37.6°C-38.1°C), gastrointestinal issues
- Treatment
- Vaccination and boosters; symptom management.
